Penn Medicine Provider
Cardiology, Medical Genetics
Daniel J. Rader, MD
4.9
(60)
Accepting new patients
Sees patients age 18 and up
Penn Translational Medicine and Human Genetics
View 1 additional location

About me

  • Chief, Division of Translational Medicine and Human Genetics
  • Chair, Department of Genetics
  • Associate Director, Institute for Translational Medicine and Therapeutics
  • Seymour Gray Professor of Molecular Medicine
  • Professor of Medicine in Genetics
  • Professor of Medicine in Pediatrics
  • Professor of Medicine in Pharmacology (Experimental Therapeutics)

Education and training

  • Medical School: Medical College of Pennsylvania
  • Residency: Yale-New Haven Hospital

What my patients think about me

Average Rating
4.9

60 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
best in field
February 2025
5.0
5.0
seemed very knowledgeable and professional
February 2025
5.0
5.0
provided direct, definitive recommendations
February 2025
5.0
5.0
dr rader is the best and highly educated in this area

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Rader is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Liu H, Abedini A, Ha E, Ma Z, Sheng X, Dumoulin B, Qiu C, Aranyi T, Li S, Dittrich N, Chen HC, Tao R, Tarng DC, Hsieh FJ, Chen SA, Yang SF, Lee MY, Kwok PY, Wu JY, Chen CH, Khan A, Limdi NA, Wei WQ, Walunas TL, Karlson EW, Kenny EE, Luo Y, Kottyan L, Connolly JJ, Jarvik GP, Weng C, Shang N, Cole JB, Mercader JM, Mandla R, Majarian TD, Florez JC, Haas ME, Lotta LA; Regeneron Genetics Center‡; GHS-RGC DiscovEHR Collaboration§; Drivas TG; Penn Medicine BioBank¶; Vy HMT, Nadkarni GN, Wiley LK, Wilson MP, Gignoux CR, Rasheed H, Thomas LF, Åsvold BO, Brumpton BM, Hallan SI, Hveem K, Zheng J, Hellwege JN, Zawistowski M, Zöllner S, Franceschini N, Hu H, Zhou J, Kiryluk K, Ritchie MD, Palmer M, Edwards TL, Voight BF, Hung AM, Susztak K; Regeneron Genetics Center; GHS-RGC DiscovEHR Collaboration; Penn Medicine BioBank. Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants , Science, 387: 2025,eadp4753


Borja NA, Tinker RJ, Bivona SA, Smith CA, Locker TK, Fernandes S; Undiagnosed Diseases Network; Phillips JA 3rd, Stoler J, Taylor H, Zuchner S, Tekin M. Advancing Equity in Rare Disease Research: Insights From the Undiagnosed Disease Network , Am J Med Genet A, 197(2): 2025,e63904


Fan Z, Chirinos J, Yang X, Shu J, Li Y, O'Brien JM, Witschey W, Rader DJ, Gur R, Zhao B. The landscape of plasma proteomic links to human organ imaging , medRxiv: 2025


Borja NA, Zafeer MF, Bivona S, Peart L, Gultekin SH; Undiagnosed Diseases Network; Bademci G, Tekin M; Undiagnosed Diseases Network NIH. KIF21A-associated peripheral neuropathy defined by impaired binding with TUBB3 , J Med Genet, 62: 2025,117-122


Tian L, Jaeger BC, Scialla JJ, Budoff MJ, Mehta RC, Jaar BG, Saab G, Dobre MA, Reilly MP, Rader DJ, Townsend RR, Lash JP, Greenland P, Isakova T, Bundy JD; CRIC Study Investigators. Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study , Am J Kidney Dis, 85(1): 2025,67-77


Powers J, Wachtel H, Trujillo E, Desai H, Hausler R, Conway L, Wubbenhorst B; Penn Medicine BioBank; Regeneron Genetics Center; Domchek SM, Nathanson KL, Maxwell KN. Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive risk , Genet Med, 27(1): 2025,101246


Weng LC, Rämö JT, Jurgens SJ, Khurshid S, Chaffin M, Hall AW, Morrill VN, Wang X, Nauffal V, Sun YV, Beer D, Lee S, Nadkarni GN, Duong T, Wang B, Czuba T, Austin TR, Yoneda ZT, Friedman DJ, Clayton A, Hyman MC, Judy RL, Skanes AC, Orland KM, Treu TM, Oetjens MT, Alonso A, Soliman EZ, Lin H, Lunetta KL, van der Pals J, Issa TZ, Nafissi NA, May HT, Leong-Sit P, Roselli C, Choi SH; FinnGen; Million Veteran Program; Regeneron Genetics Center; Khan HR, Knight S, Karlsson Linnér R, Bezzina CR, Ripatti S, Heckbert SR, Gaziano JM, Loos RJF, Psaty BM, Smith JG, Benjamin EJ, Arking DE, Rader DJ, Shah SH, Roden DM, Damrauer SM, Eckhardt LL, Roberts JD, Cutler MJ, Shoemaker MB, Haggerty CM, Cho K, Palotie A, Wilson PWF, Ellinor PT, Lubitz SA. The impact of common and rare genetic variants on bradyarrhythmia development , Nat Genet, 57(1): 2025,53-64


Fitzsimmons L; Undiagnosed Diseases Network; Beaulieu-Jones B, Kobren SN. Enriched phenotypes in rare variant carriers suggest pathogenic mechanisms in rare disease patients , BioData Min, 18: 2025,6


Abramowitz SA, Boulier K, Keat K, Cardone KM, Shivakumar M, DePaolo J, Judy R, Bermudez F, Mimouni N, Neylan C, Kim D, Rader DJ, Ritchie MD, Voight BF, Pasaniuc B, Levin MG, Damrauer SM; Penn Medicine BioBank. Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores , JAMA, 333: 2025,60-70


Kember RL, Verma SS, Verma A, Xiao B, Lucas A, Kripke CM, Judy R, Chen J, Damrauer SM, Rader DJ, Ritchie MD. Polygenic risk scores for cardiometabolic traits demonstrate importance of ancestry for predictive precision medicine , Pac Symp Biocomput, 30: 2025,748-765


View all publications